These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11982608)

  • 1. Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers.
    Batiuk TD; Bodziak KA; Goldman M
    Clin Transplant; 2002 Feb; 16(1):1-8. PubMed ID: 11982608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians.
    Ison MG; Stosor V
    Clin Transplant; 2009; 23(6):866-73. PubMed ID: 19473202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers.
    Spital A
    Transplantation; 1998 May; 65(9):1187-91. PubMed ID: 9603166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.
    Theodoropoulos N; Ladner DP; Ison MG
    Transpl Infect Dis; 2013 Oct; 15(5):545-9. PubMed ID: 23901896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of repeat testing of living kidney donors within 14 days of the transplant procedure: a multicenter retrospective survey.
    Echenique IA; Cohen D; Rudow DL; Ison MG
    Transpl Infect Dis; 2014 Jun; 16(3):403-11. PubMed ID: 24796964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
    Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
    Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of dental care protocols among US organ transplant centers.
    Guggenheimer J; Mayher D; Eghtesad B
    Clin Transplant; 2005 Feb; 19(1):15-8. PubMed ID: 15659128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in immunization guidelines in children before and after lung transplantation.
    Benden C; Danziger-Isakov LA; Astor T; Aurora P; Bluemchen K; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Michaels MG; Mogayzel PJ; Mueller C; Parakininkas D; Oberkfell D; Solomon M; Boehler A
    Pediatr Transplant; 2007 Dec; 11(8):882-7. PubMed ID: 17976123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients.
    Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA
    Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines, Antibodies and Donors: Varying Attitudes and Policies Surrounding COVID-19 and Heart Transplantation.
    Defilippis EM; Allen LA; Bhatt AS; Joseph S; Kittleson M; Vardeny O; Drazner MH; Lala A
    J Card Fail; 2022 Dec; 28(12):1727-1732. PubMed ID: 35718306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations.
    Elamin S; Abu-Aisha H
    Arab J Nephrol Transplant; 2011 Jan; 4(1):35-47. PubMed ID: 21469594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
    Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
    BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection and lung transplantation: a survey of practices.
    Cotler SJ; Jensen DM; Kesten S
    J Heart Lung Transplant; 1999 May; 18(5):456-9. PubMed ID: 10363690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    Noble S; Faulds D
    Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral prophylaxis in organ transplant patients.
    Slifkin M; Doron S; Snydman DR
    Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.